Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial

Abstract Deeper responses are associated with longer survival in multiple myeloma (MM); however, limited data exist on the impact of response kinetics on outcomes. We investigated progression‐free survival (PFS) and duration of response (DOR) by response depth and in early (best confirmed response 0...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Paul G. Richardson, Thierry Facon, Christopher P. Venner, Nizar J. Bahlis, Fritz Offner, Darrell White, Lionel Karlin, Lotfi Benboubker, Eric Voog, Sung‐Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Miguel Villarreal, Philip Twumasi‐Ankrah, Richard Labotka, Robert M. Rifkin, Sagar Lonial, Shaji K. Kumar, S. Vincent Rajkumar, Philippe Moreau
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-11-01
Colecção:	eJHaem
Assuntos:	depth of response ixazomib multiple myeloma response kinetics
Acesso em linha:	https://doi.org/10.1002/jha2.759
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!